SCHEMBL24179797

SCHEMBL24179797

Cc1ccc(CCNC(=O)CCCS)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.63
HDAC1 Q13547 2/20 0.63
HDAC2 Q92769 2/20 0.63
HDAC10 Q969S8 2/20 0.63
HDAC11 Q96DB2 2/20 0.63
HDAC8 Q9BY41 2/20 0.63
HDAC6 Q9UBN7 2/20 0.63
POLB P06746 2/20 0.59
KMT2A Q03164 2/20 0.59
HPGD P15428 2/20 0.55
LMNA P02545 2/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA9 Q16790 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.53
RAB9A P51151 2/20 0.53
PLAAT3 P53816 2/20 0.52
PLAAT5 Q96KN8 2/20 0.52
PLAAT2 Q9NWW9 2/20 0.52
PLAAT4 Q9UL19 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25868917 0.84 POLB (0.59) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL25834953 0.84 POLB (0.59) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL7295274 0.84 RAB9A (0.60) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL26998004 0.84 POLB (0.59) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL17335855 0.82 HPGD (0.73) POLBKMT2AHPGDLMNASMN1; SMN2
SCHEMBL17117413 0.82 PLAAT3 (0.68) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL17077863 0.81 HDAC3 (0.52) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL25594203 0.80 RAB9A (0.55) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL15679869 0.79 PLAAT3 (0.73) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL10408493 0.79 KMT2A (0.61) HDAC2HDAC8POLBKMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11220523-B2 Carbohydrate ligands that bind to IgM antibodies against myelin-associated glycoprotein UNIVERSITÄT BASEL (CH) 2022-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11220523-B2 Carbohydrate ligands that bind to IgM antibodies against myelin-associated glycoprotein MAG, PMP22, SIGLEC7 HDAC3 1773/4885HDAC1 858/4885HDAC2 1313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.